hepatocellular carcinoma
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
hepatocellular carcinoma
May 15, 2024, 14:07 |
Blog
Rasha Aboelhassan: I'm honoured to be a part of the HCC committee in Nasser Institute
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: “Management of…
May 5, 2024, 13:13 |
Blog
Dr. Tim Greten receives 2024 Innovation Grant from the Cholangiocarcinoma Foundation! - NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn: "STAFF SPOTLIGHT: Congratulations to Dr. Tim Greten, the…
May 2, 2024, 01:42 |
Opinion
Sharlene Gill: My picks for special oral abstract mentions for ASCO24
Sharlene Gill shared on X: "Here we go - less than 5 weeks to ASCO24.…
Apr 26, 2024, 17:42 |
Insight
New Paper Alert! The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms
The Role of MicroRNAs in Hepatocellular Carcinoma: Understanding Tumor Microenvironment and Drug Resistance Mechanisms Authors:…
Apr 13, 2024, 14:18 |
Insight
Jonathan Cohen discusses hepatocellular carcinoma at the annual meeting of the Israeli Oncology Society
Jonathan Cohen, Director of Clinical Research at Sharett Institute of Oncology of Hadassah Medical Center,…
Apr 12, 2024, 17:36 |
Insight
Mark Yarchoan: Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 in 2L HCC presented at AACR24
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared on X: "Multicenter P1/2 trial of…
Apr 10, 2024, 09:52 |
Insight
David Pinato: Immunotherapy might become a novel standard of care in intermediate-stage HCC
David Pinato, Director of Developmental Cancer Therapeutics at Imperial College London, shared on LinkedIn: "Immunotherapy…
Mar 28, 2024, 02:23 |
Drugs
Angela Lamarca: Great news for patients diagnosed with Biliary Malignancies and HCC in Spain
Angela Lamarca, Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital, shared a post…
Feb 21, 2024, 18:13 |
Insight
Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Tremelimumab plus durvalumab (STRIDE)…
Jan 17, 2024, 08:54 |
Blog
Antonio D'Alessio: It is a great honor to receive my third ASCO Merit Award
Antonio D'Alessio, Clinical Research Fellow at Imperial College London, recently shared on X/Twitter: "It is…
1
2
All:
13
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube